Guangdong Hybribio BiotechLtd Balance Sheet Health
Financial Health criteria checks 4/6
Guangdong Hybribio BiotechLtd has a total shareholder equity of CN¥4.6B and total debt of CN¥74.2M, which brings its debt-to-equity ratio to 1.6%. Its total assets and total liabilities are CN¥5.1B and CN¥511.4M respectively.
Key information
1.6%
Debt to equity ratio
CN¥74.19m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥905.95m |
| Equity | CN¥4.58b |
| Total liabilities | CN¥511.43m |
| Total assets | CN¥5.09b |
Recent financial health updates
Recent updates
Guangdong Hybribio Biotech Co.,Ltd.'s (SZSE:300639) Share Price Boosted 45% But Its Business Prospects Need A Lift Too
Oct 08
Is Guangdong Hybribio BiotechLtd (SZSE:300639) Using Debt In A Risky Way?
Sep 29Guangdong Hybribio Biotech Co.,Ltd.'s (SZSE:300639) 77% Share Price Surge Not Quite Adding Up
Aug 19Guangdong Hybribio BiotechLtd (SZSE:300639) Is Reducing Its Dividend To CN¥0.065
May 22There May Be Some Bright Spots In Guangdong Hybribio BiotechLtd's (SZSE:300639) Earnings
May 03Financial Position Analysis
Short Term Liabilities: 300639's short term assets (CN¥2.5B) exceed its short term liabilities (CN¥380.9M).
Long Term Liabilities: 300639's short term assets (CN¥2.5B) exceed its long term liabilities (CN¥130.5M).
Debt to Equity History and Analysis
Debt Level: 300639 has more cash than its total debt.
Reducing Debt: 300639's debt to equity ratio has increased from 0% to 1.6% over the past 5 years.
Debt Coverage: 300639's debt is well covered by operating cash flow (234.3%).
Interest Coverage: Insufficient data to determine if 300639's interest payments on its debt are well covered by EBIT.